Literature DB >> 903775

Cerebral dominance for language in cerebral palsy.

P T Quinn, G Andrews.   

Abstract

A test of cerebral dominance for language was administered to 51 cerebral palsied adults. The test consisted of dichotically presented words and in normal speaking adults had previously demonstrated very marked right ear superiority, interpreted as left cerebral dominance. The group of cerebral palsied subjects did not show the predicted right ear superiority. This finding may represent a chance maldistribution of side of cerebral injury within the 51 subjects. If substantiated, however, it would suggest either that the cortical damage in cerebral palsy is commonly widespread or else that the inherent left cerebral dominance of neonates is less tenacious than is generally assumed.

Entities:  

Mesh:

Year:  1977        PMID: 903775      PMCID: PMC492769          DOI: 10.1136/jnnp.40.6.608

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  5 in total

1.  The reliability of ear advantage in dichotic listening.

Authors:  S Blumstein; H Goodglass; V Tartter
Journal:  Brain Lang       Date:  1975-04       Impact factor: 2.381

2.  INTRACAROTID SODIUM AMYTAL FOR THE LATERALIZATION OF CEREBRAL SPEECH DOMINANCE; OBSERVATIONS IN 123 PATIENTS.

Authors:  C BRANCH; B MILNER; T RASMUSSEN
Journal:  J Neurosurg       Date:  1964-05       Impact factor: 5.115

3.  Hemiplegia of early onset and the faculty of speech with special reference to the effects of hemispherectomy.

Authors:  L S BASSER
Journal:  Brain       Date:  1962-09       Impact factor: 13.501

4.  Left hemisphere specialization for language in the newborn. Neuroanatomical evidence of asymmetry.

Authors:  S F Witelson; W Pallie
Journal:  Brain       Date:  1973-09       Impact factor: 13.501

5.  Human brain: left-right asymmetries in temporal speech region.

Authors:  N Geschwind; W Levitsky
Journal:  Science       Date:  1968-07-12       Impact factor: 47.728

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.